512036 — Skybiotech Healthcare Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹364.33m
- IN₹454.50m
- IN₹70.52m
Annual cashflow statement for Skybiotech Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | — | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.482 | -0.378 | -0.074 | 18.7 | -24.3 |
| Depreciation | |||||
| Non-Cash Items | 13 | 6.49 | -3.45 | -31.1 | 4.12 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.284 | -0.038 | -0.002 | -1 | 4.29 |
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 12.8 | 6.1 | -3.51 | -13.4 | -10.4 |
| Capital Expenditures | — | — | — | — | -3.25 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -12.7 | -6.16 | 3.57 | 36.3 | -93 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -12.7 | -6.16 | 3.57 | 36.3 | -96.3 |
| Financing Cash Flow Items | — | — | — | — | -0.12 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | — | — | 61.3 | 12.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.065 | -0.06 | 0.058 | 84.2 | -94.3 |